|
ATXN7L3B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.84741111297626E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.59872115546023E-14 |
| Normal-vs-Stage2 |
3.7379000000004E-05 |
| Normal-vs-Stage3 |
7.645100E-04 |
| Normal-vs-Stage4 |
2.955600E-01 |
| Stage1-vs-Stage2 |
5.901200E-01 |
| Stage1-vs-Stage3 |
1.103970E-01 |
| Stage1-vs-Stage4 |
9.438200E-02 |
| Stage2-vs-Stage3 |
4.164400E-01 |
| Stage2-vs-Stage4 |
3.641400E-01 |
| Stage3-vs-Stage4 |
5.620600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.51212375953946E-13 |
| Normal-vs-AfricanAmerican |
1.57879000000083E-05 |
| Normal-vs-Asian |
8.045700E-04 |
| Caucasian-vs-AfricanAmerican |
2.840800E-01 |
| Caucasian-vs-Asian |
7.473000E-01 |
| AfricanAmerican-vs-Asian |
9.542600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.65456537359887E-12 |
| Normal-vs-Female |
2.1331999999985E-05 |
| Male-vs-Female |
1.002560E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.51719999955213E-07 |
| Normal-vs-Extreme_Weight |
3.78919118304566E-13 |
| Normal-vs-Obese |
8.12600000000829E-05 |
| Normal-vs-Extreme_Obese |
1.7454000023065E-08 |
| Normal_Weight-vs-Extreme_Weight |
4.641000E-01 |
| Normal_Weight-vs-Obese |
2.757200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.655600E-01 |
| Extreme_Weight-vs-Obese |
3.913700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.411400E-01 |
| Obese-vs-Extreme_Obese |
6.182300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.790300E-02 |
| Normal-vs-Age(41-60Yrs) |
1.68130000033351E-07 |
| Normal-vs-Age(61-80Yrs) |
3.21964677141295E-15 |
| Normal-vs-Age(81-100Yrs) |
3.801600E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.024600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.521500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.909600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.895500E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.272970E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.467800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.76196859722222E-12 |
| Normal-VS-Type2 PRCC |
8.37219182869831E-13 |
| Normal-VS-KIRP CIMP |
1.215610E-01 |
| Normal-VS-Unclassified PRCC |
1.632020E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.458800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.843440E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.469590E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.267700E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
7.793700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.130800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.60909952029442E-10 |
| Normal-vs-N1 |
3.362800E-01 |
| Normal-vs-N2 |
3.101000E-03 |
| N0-vs-N1 |
1.089910E-02 |
| N0-vs-N2 |
4.979000E-01 |
| N1-vs-N2 |
1.118030E-01 |
|
|
